GLP-1 medications can come with side effects—these are the vitamins and supplements that helped me navigate and manage them ...

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

If you want to talk to your health care provider about weight loss medications, Saxenda and Zepbound are two options you may ...

Eli Lilly said its obesity drug Zepbound led to more weight loss than its main rival, Novo Nordisk's Wegovy, in the first head-to-head clinical trial on the two weekly injections. The findings suggest ...

Zepbound and Mounjaro are brand-name injections with the same active ingredient: tirzepatide. Neither Zepbound nor Mounjaro is available as a generic drug. However, various forms of compounded ...

Eli Lilly Canada announced today that Health Canada has approved ZEPBOUND® (tirzepatide injection) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity (BMI 30 ...

"In the SURMOUNT-5 trial, Zepbound demonstrated a significantly higher magnitude of weight reduction compared to Wegovy across all comparisons," said Leonard Glass, MD, FACE, senior vice president, ...

CHARLOTTE, N.C. (QUEEN CITY NEWS) — As the popularity of GLP-1 medications for weight loss continues to soar, experts in ...

All doses of Eli Lilly's highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug Administration's drug ...

KELOWNA, BC / ACCESS Newswire / March 18, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to ...

Contrave and Zepbound are two U.S. Food and Drug Administration (FDA)-approved medications for weight loss when combined with diet and exercise. But each medication works in different ways in the body ...